Skip to main content

Taysha Doses Patient #2 and Provides Additional Updates

September 26, 2023
Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome

On September 26 Taysha Gene Therapies shared new information with the community about progress with its clinical trial in Canada for adults with Rett syndrome, and plans to expand to pediatric clinical trials in the US and the UK.

$40M